Conclusion
This review aims to summarize the existing evidence regarding the role
of CAC in the prediction of CVA. Currently, available data shows that
CAC is a viable predictor of CVA risk, and that utilizing it (In
addition to well-established stroke risk factors) may allow improved
risk stratification, therefore allowing clinicians to better tailor
their approach to each patient. In addition, CAC may also guide better
management in patients with a pre-existing history of stroke, as using
it in addition to other validated measures, such as the PRECORIS score,
may similarly aid the clinician in the identification of those at risk
of CAD, which is an important cause of morbidity in stroke survivors.